Archived Podcasts

Prognostic Predictors and Outcomes in Patients with Abnormal Myocardial Perfusion Imaging and Angiographically Insignificant Coronary Artery Disease
Prognostic Predictors and Outcomes in Patients with Abnormal Myocardial Perfusion Imaging and Angiographically Insignificant Coronary Artery Disease
In this podcast episode, Dr. Kenneth Brown of the University of Vermont College of Medicine discusses a new study that explores outcomes in patients with abnormal stress myocardial perfusion imaging suggestive of ischemia but angiographically insignificant coronary artery disease. Often labeled as "false positives", these patients are still at risk for major cardiac events according to the study's authors.
Prospective Evaluation of the Impact of Diabetes and Left Ventricular Hypertrophy on the Relationship Between Ischemia and Transient Ischemic Dilation of the Left Ventricle on Single Day Adenosine Tc99 Myocardial Perfusion Imaging
Prospective Evaluation of the Impact of Diabetes and Left Ventricular Hypertrophy on the Relationship Between Ischemia and Transient Ischemic Dilation of the Left Ventricle on Single Day Adenosine Tc99 Myocardial Perfusion Imaging
Dr. Aiden Abidov of William Beaumont Hospital and Cedars-Sinai Medical Center discusses the merits of this study and the controversy of TID ratio thresholds given the absence of literature on thresholds for single-day adenosine Tc-99m sestamibi protocols.
Different Manifestations of Coronary Artery Disease by Stress SPECT Myocardial Perfusion Imaging, Coronary Calcium Scoring and Multi-Slice CT Coronary Angiography in Asymptomatic Patients with Type 2 Diabetes Mellitus
Different Manifestations of Coronary Artery Disease by Stress SPECT Myocardial Perfusion Imaging, Coronary Calcium Scoring and Multi-Slice CT Coronary Angiography in Asymptomatic Patients with Type 2 Diabetes Mellitus
Dr. Todd Miller of the Mayo Clinic discusses the potential of three imaging modalities in detecting coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. Listen to Dr. Miller's review of this important study published in the July/August 2008 issue of the JNC. Disclosure: Dr. Miller receives research funding from Lantheus Medical Imaging and Molecular Insight Pharmaceuticals and has consulting arrangements with TherOx, Inc. and The Medicines Company.